Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. Reply
- PMID: 31042847
- DOI: 10.1056/NEJMc1902336
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. Reply
Comment on
-
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.N Engl J Med. 2019 May 2;380(18):e32. doi: 10.1056/NEJMc1902336. N Engl J Med. 2019. PMID: 31042845 No abstract available.
-
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.N Engl J Med. 2019 May 2;380(18):e32. doi: 10.1056/NEJMc1902336. N Engl J Med. 2019. PMID: 31042846 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources